287 related articles for article (PubMed ID: 34248856)
1. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
Murakami T; Fujimoto H; Inagaki N
Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
Joosten L; Brom M; Peeters H; Heskamp S; Béhé M; Boerman O; Gotthardt M
Mol Pharm; 2018 Feb; 15(2):486-494. PubMed ID: 29226686
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of an
Kimura H; Fujita N; Kanbe K; Matsuda H; Watanabe H; Arimitsu K; Fujimoto H; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
Bioorg Med Chem; 2017 Oct; 25(20):5772-5778. PubMed ID: 28927802
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.
Brom M; Woliner-van der Weg W; Joosten L; Frielink C; Bouckenooghe T; Rijken P; Andralojc K; Göke BJ; de Jong M; Eizirik DL; Béhé M; Lahoutte T; Oyen WJ; Tack CJ; Janssen M; Boerman OC; Gotthardt M
Diabetologia; 2014 May; 57(5):950-9. PubMed ID: 24488022
[TBL] [Abstract][Full Text] [Related]
5. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis.
Joosten L; Brom M; Peeters H; Bos D; Himpe E; Bouwens L; Boerman O; Gotthardt M
Mol Pharm; 2019 Sep; 16(9):4024-4030. PubMed ID: 31345042
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT.
Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Matsumoto K; Inagaki N
Endocrinology; 2019 Dec; 160(12):2959-2968. PubMed ID: 31613319
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.
Kiyobayashi S; Murakami T; Harada N; Fujimoto H; Murata Y; Fujita N; Hamamatsu K; Ikeguchi-Ogura E; Hatoko T; Lu X; Yamane S; Inagaki N
Front Endocrinol (Lausanne); 2022; 13():921125. PubMed ID: 35909510
[TBL] [Abstract][Full Text] [Related]
8. Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using
Fauzi M; Murakami T; Fujimoto H; Botagarova A; Sakaki K; Kiyobayashi S; Ogura M; Inagaki N
Front Endocrinol (Lausanne); 2022; 13():1010825. PubMed ID: 36246910
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive longitudinal quantification of β-cell mass with [
Fujita N; Fujimoto H; Hamamatsu K; Murakami T; Kimura H; Toyoda K; Saji H; Inagaki N
FASEB J; 2019 Nov; 33(11):11836-11844. PubMed ID: 31370679
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with
Hamamatsu K; Fujimoto H; Fujita N; Murakami T; Shiotani M; Toyoda K; Inagaki N
Sci Rep; 2019 Dec; 9(1):18338. PubMed ID: 31797889
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
[TBL] [Abstract][Full Text] [Related]
12. Development of
Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive quantitative evaluation of viable islet grafts using
Botagarova A; Murakami T; Fujimoto H; Fauzi M; Kiyobayashi S; Otani D; Fujimoto N; Inagaki N
FASEB J; 2023 Apr; 37(4):e22859. PubMed ID: 36906290
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive in vivo determination of viable islet graft volume by
Eter WA; Van der Kroon I; Andralojc K; Buitinga M; Willekens SMA; Frielink C; Bos D; Joosten L; Boerman OC; Brom M; Gotthardt M
Sci Rep; 2017 Aug; 7(1):7232. PubMed ID: 28775287
[TBL] [Abstract][Full Text] [Related]
17. First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [
Fujimoto H; Fujita N; Hamamatsu K; Murakami T; Nakamoto Y; Saga T; Ishimori T; Shimizu Y; Watanabe H; Sano K; Harada N; Nakamura H; Toyoda K; Kimura H; Nakagawa S; Hirai M; Murakami A; Ono M; Togashi K; Saji H; Inagaki N
Front Endocrinol (Lausanne); 2021; 12():717101. PubMed ID: 34489868
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
